A small Los Angeles-based company is up big in early trade after it announced that it has begun the sales and distribution across the U.S. of COVID-19 IgG/IgM Antibody Rapid Test Kits. The Rapid Test Kit detects antibodies to SARS-CoV-2 with 97% accuracy in less than 15 minutes, and provides an affordable and convenient home/office testing solution for individuals who want to know if they have been previously infected with the virus or before and after receiving a vaccine to monitor their levels of antibodies, according to the release.
GTX Corp (OTC-PNK:GTXO) along with its subsidiaries, is engaged in designing, development, manufacturing, distribution, and sales of products and services in the GPS and BLE wearable technology personal location and wandering assistive technology business.
The company generates its revenue from the sale of GPS tracking devices, related monthly fees, the sale of GPS SmartSole, monthly service fee from subscribers of the GPS SmartSole, and mobile tracking applications sold through Apple iTunes store and Google marketplace.
Traders seemed eager to get their hands on shares as they traded up to an early session high of $0.016/share (+68.4%). This move broke above the 100-day SMA after the stock found support at its 50-day SMA just one day ago.
